Published in J Infect Dis on June 01, 1987
Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis. BMJ (2013) 3.72
Urease-positive bacteriuria and obstruction of long-term urinary catheters. J Clin Microbiol (1987) 3.08
Proteus mirabilis urease: nucleotide sequence determination and comparison with jack bean urease. J Bacteriol (1989) 2.92
Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J Bacteriol (2008) 2.47
Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev (2008) 2.45
Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect Immun (1990) 2.12
Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev (1996) 2.10
Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes. J Bacteriol (1988) 2.04
Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect Immun (1993) 1.82
Potential virulence factors of Proteus bacilli. Microbiol Mol Biol Rev (1997) 1.68
Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells. Infect Immun (1991) 1.61
Role of biofilm in catheter-associated urinary tract infection. Am J Infect Control (2004) 1.32
Barriers to and facilitators of clinical practice guideline use in nursing homes. J Am Geriatr Soc (2007) 1.27
Expression of type 1 fimbriae may be required for persistence of Escherichia coli in the catheterized urinary tract. J Clin Microbiol (1987) 1.27
Visualization of Proteus mirabilis morphotypes in the urinary tract: the elongated swarmer cell is rarely observed in ascending urinary tract infection. Infect Immun (2003) 1.16
Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation. J Bacteriol (2007) 1.16
Asymptomatic bacteriuria: when the treatment is worse than the disease. Nat Rev Urol (2011) 1.03
Uropathogens and host characteristics. J Clin Microbiol (2008) 1.01
Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection. Infect Immun (2010) 1.01
Escherichia coli isolates causing asymptomatic bacteriuria in catheterized and noncatheterized individuals possess similar virulence properties. J Clin Microbiol (2010) 1.00
Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection. Infect Immun (2008) 0.95
Catheter associated urinary tract infections. Antimicrob Resist Infect Control (2014) 0.94
Urethral obstruction of 6 hours or less causes bacteriuria, bacteremia, and pyelonephritis in mice challenged with "nonuropathogenic" Escherichia coli. Infect Immun (1993) 0.91
Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression. Infect Immun (2011) 0.90
Proteus mirabilis urease: histidine 320 of UreC is essential for urea hydrolysis and nickel ion binding within the native enzyme. Infect Immun (1993) 0.87
Direct ureteric length measurement from intravenous pyelography: does height represent ureteric length? Urol Res (2005) 0.85
Outer membrane protein profiles and multilocus enzyme electrophoresis analysis for differentiation of clinical isolates of Proteus mirabilis and Proteus vulgaris. J Clin Microbiol (1992) 0.83
Standards of therapy for urinary tract infections in adults. Infection (1992) 0.81
How Often Do Clinically Diagnosed Catheter-Associated Urinary Tract Infections in Nursing Homes Meet Standardized Criteria? J Am Geriatr Soc (2016) 0.80
A metaproteomics approach to elucidate host and pathogen protein expression during catheter-associated urinary tract infections (CAUTIs). Mol Cell Proteomics (2015) 0.79
A Controlled Quasi-Experimental Study of an Educational Intervention to Reduce the Unnecessary Use of Antimicrobials For Asymptomatic Bacteriuria. PLoS One (2015) 0.78
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. Microbiol Spectr (2016) 0.77
Systematic Review of Interventions to Reduce Urinary Tract Infection in Nursing Home Residents. J Hosp Med (2017) 0.75
Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia. J Clin Microbiol (1982) 6.19
Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar. Antimicrob Agents Chemother (1983) 6.06
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun (1990) 4.94
A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis (1982) 4.37
A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nat Genet (1994) 4.20
Urease-positive bacteriuria and obstruction of long-term urinary catheters. J Clin Microbiol (1987) 3.08
Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain. Mol Microbiol (1993) 2.80
Methodology of ECG interpretation in the Dalhousie program; NOVACODE ECG classification procedures for clinical trials and population health surveys. Methods Inf Med (1990) 2.78
Pathogenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains. Infect Immun (1997) 2.21
Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect Immun (1990) 2.12
Plethysmographic Experiments on the Vaso-motor Nerves of the Limbs. J Physiol (1886) 2.12
Physicians' beliefs about the importance of 25 health promoting behaviors. Am J Public Health (1985) 2.07
Sequelae and management of urinary infection in the patient requiring chronic catheterization. J Urol (1981) 2.06
Organ-limited autopsies. Obtaining permission for postmortem examination of the urinary tract. Arch Pathol Lab Med (1995) 1.93
Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect Immun (1994) 1.91
Providencia stuartii: a common cause of antibiotic-resistant bacteriuria in patients with long-term indwelling catheters. Rev Infect Dis (1986) 1.88
Do clinical microbiology laboratories report complete bacteriology in urine from patients with long-term urinary catheters? J Clin Microbiol (1986) 1.83
Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect Immun (1993) 1.82
Controlled evaluation of the effect of atmosphere of incubation on detection of bacteremia and fungemia in supplemented peptone broth. J Clin Microbiol (1982) 1.81
Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection. Infect Immun (1996) 1.69
Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. J Urol (1987) 1.66
Proxies' decisions about clinical research participation for their charges. J Am Geriatr Soc (1997) 1.62
Shigellosis at sea: an outbreak aboard a passenger cruise ship. Am J Epidemiol (1975) 1.60
Long-term urethral catheterization increases risk of chronic pyelonephritis and renal inflammation. J Am Geriatr Soc (1994) 1.60
Withdrawal rates for infants and children participating in WIC in Maryland. J Am Diet Assoc (1997) 1.58
Health promotion: physicians' beliefs, attitudes, and practices. Am J Prev Med (1988) 1.57
Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis. Urology (2000) 1.57
Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production. J Urol (2000) 1.50
Outbreak of a multiply resistant Acinetobacter in a surgical intensive care unit: epidemiology and control. Heart Lung (1978) 1.49
MR/K hemagglutination of Providencia stuartii correlates with adherence to catheters and with persistence in catheter-associated bacteriuria. J Infect Dis (1988) 1.48
Culture and characterization of normal epithelium from cystoscopic biopsies of human bladder. In Vitro Cell Dev Biol Anim (1993) 1.47
Variable phenotypes of Providencia stuartii due to plasmid-encoded traits. J Clin Microbiol (1985) 1.45
Dietary habits, weight history, and vitamin supplement use in elderly osteoarthritis patients. J Am Diet Assoc (1989) 1.43
Pseudomonas species bacteremia caused by contaminated normal human serum albumin. J Infect Dis (1977) 1.42
Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species. Clin Infect Dis (1996) 1.41
Cost-effectiveness questioned. Md Med J (1993) 1.38
Family medicine residents' knowledge and attitudes about drug-nutrient interactions. J Am Coll Nutr (1995) 1.37
Informed consent by proxy. An issue in research with elderly patients. N Engl J Med (1986) 1.34
5 A Day for better health--nine community research projects to increase fruit and vegetable consumption. Public Health Rep (1995) 1.33
Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice. Infect Immun (1998) 1.32
Internalization of Proteus mirabilis by human renal epithelial cells. Infect Immun (1994) 1.29
Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancer. Arch Intern Med (1986) 1.29
A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections. Surg Gynecol Obstet (1982) 1.28
Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats. J Antimicrob Chemother (1983) 1.27
Expression of type 1 fimbriae may be required for persistence of Escherichia coli in the catheterized urinary tract. J Clin Microbiol (1987) 1.27
Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients. J Urol (1996) 1.27
Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med (1978) 1.27
Guidelines for infection control in intravenous therapy. Ann Intern Med (1973) 1.24
Botulism and botulism-like illness in chronic drug abusers. Ann Intern Med (1985) 1.21
Cardiac infarction injury score: an electrocardiographic coding scheme for ischemic heart disease. Circulation (1981) 1.19
Factors associated with fruit and vegetable consumption among women participating in WIC. J Am Diet Assoc (1998) 1.19
Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls. J Urol (1997) 1.16
Infection with Mycoplasma hominis in postpartum fever. Lancet (1980) 1.16
Molecular epidemiology of group JK Corynebacterium on a cancer ward: lack of evidence for patient-to-patient transmission. J Infect Dis (1986) 1.14
Final results of the Maryland WIC 5-A-Day Promotion Program. Am J Public Health (1998) 1.14
Successful treatment of Brucella melitensis end-carditis. Am J Med (1978) 1.11
A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli. Rev Infect Dis (1983) 1.11
Comparative evaluation of supplemented peptone broth with sodium polyanetholesulfonate and trypticase soy broth with sodium amylosulfate for detection of septicemia. J Clin Microbiol (1982) 1.10
Wide variation in risk of wound infection following clean neurosurgery. Implications for perioperative antibiotic prophylaxis. J Neurosurg (1985) 1.09
Cost-effectiveness of assertive community treatment for homeless persons with severe mental illness. Br J Psychiatry (1999) 1.09
Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA (1982) 1.08
How frequent are outbreaks of nosocomial infection in community hospitals? Infect Control (1985) 1.07
Hepatitis B in Nuremberg, Germany. Epidemiology of a drug-associated epidemic. Among US Army soldiers. JAMA (1975) 1.04
In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents. Antimicrob Agents Chemother (1985) 1.02
Psychosocial factors and intervention-associated changes in those factors as correlates of change in fruit and vegetable consumption in the Maryland WIC 5 A Day Promotion Program. Ann Behav Med (2000) 1.02
A diagnostic in vitro urine assay for interstitial cystitis. Urology (1998) 1.02
Acute pyelonephritis associated with bacteriuria during long-term catheterization: a prospective clinicopathological study. J Infect Dis (1988) 1.01
The Knee-jerk and its Physiological Modifications. J Physiol (1890) 1.01
Bacteriuria in a population-based cohort of women. J Infect Dis (1978) 1.00
Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. Am J Infect Control (1988) 0.98
Immunization against typhoid fever. Annu Rev Med (1979) 0.98
Depletion of intracellular Ca2+ by caffeine and ryanodine induces apoptosis of chinese hamster ovary cells transfected with ryanodine receptor. J Biol Chem (2000) 0.98
Phospholipase Cdelta1 is a guanine nucleotide exchanging factor for transglutaminase II (Galpha h) and promotes alpha 1B-adrenoreceptor-mediated GTP binding and intracellular calcium release. J Biol Chem (2000) 0.97
Mouse models of short- and long-term foreign body in the urinary bladder: analogies to the bladder segment of urinary catheters. Lab Anim Sci (1991) 0.94
The prevalence of urethral catheterization in Maryland nursing homes. Arch Intern Med (1989) 0.94
Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis. J Urol (2000) 0.94
Estimation of QT prolongation. A persistent, avoidable error in computer electrocardiography. J Electrocardiol (1990) 0.93
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. Am J Med (1986) 0.93
The HIV epidemic and the primary care physician. Md Med J (1991) 0.93
Sensitivity, precision, and accuracy of the Y1 adrenal cell enterotoxin assay. J Clin Microbiol (1979) 0.93
Anaerobic septic arthritis. Clin Orthop Relat Res (1982) 0.92